FDA Approves First Generic Blood Thinner Enoxaparin Sodium Injection
The U.S. FDA (Food and Drug Administration) announced it has approved the 1st generic version of enoxaparin sodium injection (Lovenox), an anti-coagulant (blood thinner) used for the prevention of DVT (deep vein thrombosis), as well as some other therapies. Lovenox is made from heparin and was approved for use in the USA in 1993. It is a blood-thinning medication whose active ingredient is a naturally-derived complex mixture of sugar molecules.
Read the full story here
-
FDA Recommends Dropping Low Blood Pressure Drug Midodrine Hydrochloride
GSK Receives CHMP Positive Opinion For A New Indication For Arixtra
Cialis’ active ingredient approved for a new use
FDA Approves Melody Valve
FDA approves Effient for thrombotic cardiovascular
